ӳ����ý

By merging cancer functional genetic data with information on protein interactions, scientists can explore protein complexes at massive scale.

Repurposing existing drugs offers the potential for faster, cheaper therapy development. A new ӳ����ý-curated resource called the Drug Repurposing Hub offers comprehensive information about more than 4,700 compounds that might have additional roles to play against cancer and other diseases.

Read a on ӳ����ý’s Drug Repurposing Hub.

You can donate to the Sajni Chakrabarti Fund for DIPG Research .

Compiled by Cancer Dependency Map group, tool lets researchers identify cancer vulnerabilities.

The Cancer Genome Atlas Research Network’s systematic push to comprehensively analyze 33 forms of cancer marks the “end of the beginning” of cancer genomics.

By studying the largest collection yet of prostate cancer samples to be analyzed genomically, researchers have identified genes never before linked to prostate tumors, and started to see patterns that tell localized tumors from metastatic ones.

Internet-driven, direct-to-patient engagement allows men to volunteer medical data, speed research

An analysis of nearly 3,800 colorectal cancer patients — the largest germline risk study for this cancer to date — reveals opportunities for improved risk screening and, possibly, treatment.